Eric Ginsburg received his Ph.D. in Medicinal Chemistry from Virginia Commonwealth University in 2020. His graduate work was focused on determining the mechanism of action of platinum-based therapeutics. Upon graduation he started with Evonik as a process chemistry working in their Hopewell Virginia plant. During his time at the plant, Eric supported production by developing methods to help increase robustness of products, while minimizing reactor downtime. In December of 2021, Eric joined the Applied Innovation team, where his role is centered around the research and development of Active Ingredients.